Shares of ModernaMRNA and other vaccine stocks tumbled Monday after a Food and Drug Administration director suggested Covid ...

A quadrivalent nucleoside-modified messenger RNA influenza vaccine met superiority criteria compared with a licensed inactivated vaccine.

TÜBINGEN, DE AND BOSTON, MA / ACCESS Newswire / November 25, 2025 / CureVac N.V. (Nasdaq:CVAC)(CureVac or the Company), a ...

Correcting misinformation after it has gone viral is a common way of informing the public that what they've encountered may ...

In two experiments, researchers have found that introducing people to "mental models" about how mRNA vaccination works and ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the ...

Evo’s success wasn’t limited to proteins. When they tested a different toxin that had an RNA-based inhibitor, the system ...

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side ...

The first treatment for ATTR-CM – a once-a-day tablet called tafamidis – was approved for NHS use in 2024. According to Nice, evidence suggests vutrisiran helps people live for about as long as those ...

Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger ...

French scientists in a lab in Orleans are turning their attention to the potential of mRNA – molecules used to quickly ...

RNA therapeutics have been around since the late 1990s, but interest in these medicines has skyrocketed since the outbreak of the coronavirus pandemic and the success of messenger RNA (mRNA) vaccines.